Simplex Trading, LLC Corvus Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 5,670 shares of CRVS stock, worth $27,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,670

Previous 2,212 156.33%

Holding current value

$27,216

Previous $4,000 625.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$1.78 - $5.92 $6,155 - $20,471	3,458 Added 156.33%	5,670 $29,000
Q2 2024 Jul 25, 2024	SELL	$1.36 - $2.29 $9,702 - $16,336	-7,134 Reduced 76.33%	2,212 $4,000
Q1 2024 Apr 25, 2024	SELL	$1.76 - $2.41 $70,901 - $97,086	-40,285 Reduced 81.17%	9,346 $16,000
Q4 2023 Feb 02, 2024	BUY	$1.08 - $1.92 $10,949 - $19,464	10,138 Added 25.67%	49,631 $87,000
Q3 2023 Nov 01, 2023	BUY	$1.41 - $2.97 $39,429 - $83,053	27,964 Added 242.55%	39,493 $57,000
Q2 2023 Aug 04, 2023	BUY	$1.0 - $3.86 $11,529 - $44,501	11,529 New	11,529 $26,000
Q4 2022 Feb 02, 2023	BUY	$0.74 - $1.04 $3,973 - $5,583	5,369 Added 33.45%	21,419 $18,000
Q3 2022 Nov 04, 2022	SELL	$0.71 - $1.17 $6,779 - $11,171	-9,548 Reduced 37.3%	16,050 $13,000
Q2 2022 Aug 03, 2022	BUY	$0.87 - $2.03 $4,805 - $11,213	5,524 Added 27.52%	25,598 $25,000
Q1 2022 May 02, 2022	BUY	$1.46 - $2.48 $29,017 - $49,290	19,875 Added 9987.44%	20,074 $32,000
Q2 2021 Aug 12, 2021	SELL	$2.46 - $3.14 $13,990 - $17,857	-5,687 Reduced 96.62%	199 $0
Q1 2021 Apr 26, 2021	BUY	$2.86 - $4.77 $16,833 - $28,076	5,886 New	5,886 $18,000
Q4 2020 Feb 02, 2021	SELL	$3.56 - $4.86 $416 - $568	-117 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$2.6 - $5.37 $304 - $628	117 New	117 $0
Q2 2020 Jul 13, 2020	SELL	$2.01 - $4.05 $293 - $591	-146 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$1.74 - $5.98 $254 - $873	146 New	146 $0

Others Institutions Holding CRVS

# of Institutions

Shares Held

30.4M

Call Options Held

1.06M

Put Options Held

84.3K

View Full List

About Corvus Pharmaceuticals, Inc.

Ticker CRVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,553,500
Market Cap $223M
Description
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...

More about CRVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Corvus Pharmaceuticals, Inc. Transaction History